The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...
Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
We spend billions searching for the cures to chronic illnesses while neglecting research that could make the daily lives of ...
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...
At long last, the FDA approved Supernus Pharmaceuticals’ Parkinson’s disease treatment, which will be marketed as Onapgo.
Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...
On Friday, Municipal Clerk Angela Harris released the latest list of hopefuls seeking to run in the 2025 municipal elections. So far, 11 candidates have filed paperwork to run for mayor, eight have ...
Although there is no cure for Parkinson's disease, medications and surgery can help relieve some of the symptoms. Alpha-synuclein is a protein in the human brain that’s involved in the release of ...
Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results